Physician-to-Physician Presentation - Gore Medical
Physician-to-Physician Presentation - Gore Medical
Physician-to-Physician Presentation - Gore Medical
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
US Clinical Trial Key LearningsGORE HELEX Septal Occluder is safe and effective for the closure of ASDsNo instances of perforation of cardiac structuresNo instances of thrombus on the deviceOptimal results when 2:1 device diameter <strong>to</strong> defect diameter ratio is used <strong>to</strong>close defects up <strong>to</strong> 18 mmClinical Trial DataDevice <strong>to</strong> Defect RatioAccess< 1.61.6 – 2.02.0 or greaterClinical Closure 92.6% 96.3% 100.0%Embolization Rate 3.0% 4.2% 0.0%Composite Success 80.0% 90.0% 95.0%*Information comes from Latson, et al., Analysis of fac<strong>to</strong>rs related <strong>to</strong> successful transcatheter closure of secundum atrial septal defects usingthe HELEX septal occluder. American Heart Journal 2006;151:1129.e7-1129.e11.